Eiger BioPharmaceuticals - Biopharmaceutical company developing a diverse portfolio of well-characterized drugs for orphan diseases.
View all
Fortress Biotech
New York, United States · Post IPO Equity
UNITY Biotechnology
San Francisco, United States · Post IPO Debt
SCYNEXIS
Jersey City, United States · Post IPO Equity
Coherus BioSciences
Redwood City, United States · Post IPO Debt
Galectin Therapeutics
Norcross, United States · Post IPO Debt
First Wave BioPharma
NY, United States · Post IPO Equity
Super League Gaming
Santa Monica, United States · Post IPO Equity
MedRhythms
Boston, United States · Series B
Halo Labs
Philadelphia, United States · Series C
Exicure
Skokie, United States · Post IPO Equity
Caladrius Biosciences
Basking Ridge, United States · IPO
Capricor Therapeutics
Beverly Hills, United States · Post IPO Equity